(BOLD) Audentes Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Audentes Therapeutics | (BOLD) share price targets
Complete technical analysis of Audentes Therapeutics (BOLD) by charts plus indicators, forecast predictions and share price targets for Audentes Therapeutics (BOLD)
Audentes Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-21 View latest technical analysis
10 day averaged volume of Audentes Therapeutics is 85900
| Date | Daily Closing Price | Open | High | Low | Volume |
| 21 Thu Nov 2024 | 2.57 | 2.74 | 2.74 | 2.50 | 1.12 times |
| 20 Wed Nov 2024 | 2.71 | 2.74 | 2.77 | 2.69 | 0.584 times |
| 19 Tue Nov 2024 | 2.69 | 2.95 | 3.00 | 2.63 | 1.017 times |
| 18 Mon Nov 2024 | 2.99 | 3.07 | 3.07 | 2.96 | 3.48 times |
| 15 Fri Nov 2024 | 3.01 | 3.30 | 3.30 | 2.89 | 1.304 times |
| 14 Thu Nov 2024 | 3.24 | 3.55 | 3.60 | 3.24 | 0.702 times |
| 13 Wed Nov 2024 | 3.57 | 3.70 | 3.75 | 3.56 | 0.523 times |
| 12 Tue Nov 2024 | 3.70 | 3.56 | 3.71 | 3.56 | 0.627 times |
| 11 Mon Nov 2024 | 3.58 | 3.52 | 3.66 | 3.31 | 0.609 times |
| 08 Fri Nov 2024 | 3.50 | 3.40 | 3.57 | 3.25 | 0.577 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 2.8, but if it comes above 2.8, then a intra day buy could be more profitable.
If you take a sell trade below 2.8, then use 2.8 as stoploss and 2.4 as target. However if you take a buy trade in stock , then use 2.8 as stoploss and 3.09 as target.
Share price targets for Audentes Therapeutics (BOLD)
| Target Type | Value |
| Downside Target | 2.50 |
| Upside Target | 2.82 |
| Upside Target | 3.04 |
| Upside Target | 3.21 |
| Upside Target | 3.40 |
| Upside Target | 3.49 |
| Upside Target | 3.57 |
| Upside Target | 3.75 |
| Upside Target | 3.96 |
| Upside Target | 4.53 |
| Upside Target | 4.72 |
Intraday share price targets for Audentes Therapeutics (BOLD)
| Target Type | Value |
| Downside Intraday Target | 2.36 |
| Downside Intraday Target | 2.14 |
| Upside Intraday Target | 2.93 |
| Upside Intraday Target | 3.28 |
| Upside Intraday Target | 2.71 |
Weekly technical analysis of Audentes Therapeutics (BOLD)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 21 Thu Nov 2024 | 2.57 | 3.07 | 3.07 | 2.50 | 1.647 times |
| 15 Fri Nov 2024 | 3.01 | 3.52 | 3.75 | 2.89 | 1.247 times |
| 08 Fri Nov 2024 | 3.50 | 3.01 | 3.57 | 2.82 | 0.914 times |
| 01 Fri Nov 2024 | 2.98 | 3.03 | 3.21 | 2.83 | 0.688 times |
| 25 Fri Oct 2024 | 2.92 | 2.94 | 3.09 | 2.82 | 1.221 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Audentes Therapeutics (BOLD)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 21 Thu Nov 2024 | 2.57 | 2.94 | 3.75 | 2.50 | 0.828 times |
| 31 Thu Oct 2024 | 2.92 | 3.49 | 3.49 | 2.82 | 1.17 times |
| 30 Mon Sep 2024 | 3.47 | 3.64 | 4.72 | 3.04 | 0.713 times |
| 30 Fri Aug 2024 | 3.62 | 3.81 | 3.96 | 2.85 | 1.081 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Audentes Therapeutics (BOLD)
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Audentes Therapeutics in short term and the sell signal is strong.
Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Audentes Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Audentes Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.05 and Audentes Therapeutics (BOLD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics (BOLD) stock. Volume based technical analysis of Audentes Therapeutics (BOLD) stock is negative.
Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Audentes Therapeutics in short term and the sell signal is strong.
Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Audentes Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Audentes Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.05 and Audentes Therapeutics (BOLD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics (BOLD) stock. Volume based technical analysis of Audentes Therapeutics (BOLD) stock is negative.
Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.